SMTL ID : 7mbo.1

FACTOR XIA (PICHIA PASTORIS; C500S [C122S]) IN COMPLEX WITH THE INHIBITOR Milvexian (BMS-986177), IUPAC NAME:(6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6- oxopyrimidin-1(6H)-yl}-1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-15,11- (metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 0.92 Å

Oligo State

monomer

Ligands

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 4 residues within 4Å: Chain A: F.74, T.101, T.102, N.104 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.104 Water bridges: A:N.104

1 x YXG: Milvexian(Non-covalent)

YXG.2: 27 residues within 4Å: Chain A: R.26, H.27, L.28, C.29, H.44, C.45, Y.47, Y.134, L.137, I.141, D.182, A.183, C.184, K.185, G.186, D.187, S.188, T.206, S.207, W.208, G.209, E.210, G.211, C.212, G.219, V.220, Y.221 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.28, A:K.185, A:T.206 Hydrogen bonds: A:R.26, A:L.28, A:K.185, A:G.186, A:D.187, A:S.188 Water bridges: A:R.26, A:R.26, A:R.26

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Dilger, A.K. et al., Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy. J.Med.Chem. (2022)

Release Date

2021-09-15

Peptides

Coagulation factor XIa light chain: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Coagulation factor XIa light chain

Related Entries With Identical Sequence